Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
Short Description: Onc dx prostate t1no progres
Coverage Code: Carrier judgment
Action Code: No maintenance for this code
Date Added: January 1, 2006
Effective Date: January 1, 2007
Termination Date: